The expression of PELP1 in TNBC was compared to clinicopathological variables including patient’s age, tumor size, lymph node stage, tumor grade, clinical stage, histological type, Ki-67 LI, and primary treatment to see if there were correlations between PELP1 and these variables. This evidence concerns the gene PELP1 and neoplasm.